James Paul Rickey - May 7, 2024 Form 4 Insider Report for ALPINE IMMUNE SCIENCES, INC. (ALPN)

Role
Senior Vice President, Chief Financial Officer and Corporate Secretary
Signature
/s/ James Paul Rickey
Stock symbol
ALPN
Transactions as of
May 7, 2024
Transactions value $
$161,629
Form type
4
Date filed
5/9/2024, 09:13 PM
Previous filing
Jan 29, 2024
Next filing
May 20, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALPN Common Stock Options Exercise $7.55 +1 +0% $7.55* 31.2K May 7, 2024 Direct F1
transaction ALPN Common Stock Options Exercise $93.1K +7.06K +22.61% $13.20* 38.3K May 7, 2024 Direct
transaction ALPN Common Stock Options Exercise $5.58K +857 +2.24% $6.51* 39.1K May 7, 2024 Direct
transaction ALPN Common Stock Options Exercise $1.85K +164 +0.42% $11.31* 39.3K May 7, 2024 Direct
transaction ALPN Common Stock Options Exercise $59.1K +18.3K +46.56% $3.23 57.6K May 7, 2024 Direct
transaction ALPN Common Stock Options Exercise $2K +398 +0.69% $5.02* 58K May 7, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -1 0% $0.00 109K May 7, 2024 Common Stock 1 $7.55 Direct F2, F3
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -7.06K -5.88% $0.00 113K May 7, 2024 Common Stock 7.06K $13.20 Direct F2, F4
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -857 -85.7% $0.00 143 May 7, 2024 Common Stock 857 $6.51 Direct F2, F5
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -164 -16.4% $0.00 836 May 7, 2024 Common Stock 164 $11.31 Direct F2, F6
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -18.3K -93.77% $0.00 1.21K May 7, 2024 Common Stock 18.3K $3.23 Direct F2, F7
transaction ALPN Stock Option (Right to buy) Options Exercise $0 -398 -74.39% $0.00 137 May 7, 2024 Common Stock 398 $5.02 Direct F2, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 31,200 shares of common stock underlying a restricted stock unit grant made on January 4, 2024.
F2 The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant.
F3 One-fourth (1/4th) of the Shares subject to the Option will vest on January 4, 2024, and one thirty-sixth (1/36th) of the remaining Shares subject to the Option shall vest each month thereafter, subject to the Reporting Person continuing to be a service provider through each such date.
F4 Twenty-five percent (25%) of the shares subject to the Option shall vest on the one (1) year anniversary of January 5, 2021 (the "Vesting Commencement Date") and one forty-eighth (1/48th) of the shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the Reporting Person continuing to be a Service Provider through each such date.
F5 100% of the shares underlying the option were fully vested as of February 6, 2023.
F6 100% of the shares underlying the option were fully vested as of January 2, 2022.
F7 100% of the shares underlying the option were fully vested as of January 23, 2024.
F8 100% of shares underlying the option were fully vested as of April 1, 2021.

Remarks:

Senior Vice President, Chief Financial Officer and Corporate Secretary